A pioneering clinical trial researching medicinal cannabis as a possibility to treat people living with Tourette syndrome is soon to be launched by Wesley Medical Research. The cannabis used in the study will be supplied by the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney.
Participants will complete two periods of treatment with either a medicinal cannabis medicine or a placebo. Both groups (including investigators) will be unaware of treatment status until the end of the trial.
We think this is great is news and all the best with the trial! More on this study can be found here: